HIGHLIGHTS
- who: Joanna Baum from the Department of Gynecology with Center for Oncological Augustenburger Platz, Germany have published the paper: Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis, in the Journal: (JOURNAL)
- what: The authors report the pharmacokinetics (PK) efficacy safety and tolerability of olaparib capsules mg BID in a patient with recurrent epithelial ovarian (EOC) and ESRD requiring hemodialysis.
SUMMARY
In the last years, the concept of maintenance therapy has been introduced and constantly developed in advanced primary and relapsed high- grade epithelial ovarian cancer (EOC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.